A users guide to measurement in medicine. Osteoarthritis Cartilage 2006, 14(suppl A):A10-A13.
(1999). A: Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks nonsteroidal anti-inflammatory drug trial. Rheumatology
(2002). Adult Treatment Panel III: Third report on National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report: IX adherence. Circulation
(2002). Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.
Calculating confidence intervals for relative risk (odds ratios) and standardised ratios and rates.
(2006). Canadian Hypertension Education Program Outcomes Research Task Force: The impact of the Canadian Hypertension Education Program on antihypertension prescribing trends. Hypertension
(1999). DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet
(2006). DM: Different methods of presenting risk information and their influence on medication compliance intentions: results of three studies. Clin Ther
(1999). Doering PL: Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis. Pharmacotherapy
(2008). Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol.
(1995). Hansten PD: Nonsteroidal anti-inflammatory drug discontinuation in patients with osteoarthritis.
(2005). HJ: Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain
(2000). HJ: An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain
(1996). HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials
(2004). HJ: Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised trials. Pain
(2006). HJ: Nonsteroidal antiinflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. BMC Musculoskelet Disord
(2005). HJ: Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther
(2005). HJ: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from clinical trial reports. Arthritis Res Ther
(2005). Hoffman BB: Improving adherence to guidelines for hypertension drug prescribing: cluster randomised controlled trial of general versus patient-specific recommendations.
(1999). Implanon: a review of clinical studies.
(2007). JM: All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis.
(2005). Kisoensingh SU: Initial phase of chronic medication use: patients' reasons for discontinuation. Br J Clin Pharmacol.
(2005). LC: Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol
(2000). LF: Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis.
(2000). Liu JLY: Misleading funnel plot for detection of bias in meta-analysis.
(2001). Nalysnyk L: Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy
(2000). Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature.
(2004). RC: Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation
(2007). Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review.
(2001). Reporting of adverse drug reactions in randomised controlled trials – a systematic survey.
(2001). Reporting of outcomes in arthritis trials measured on ordinal and interval scales is inadequate in relation to meta-analysis. Ann Rheum Dis.
(2004). RW: Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiol Drug Saf
(1995). Sackett DL: The number needed to treat: a clinically useful measure of treatment effect.
(1994). Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol
(2001). Shadforth MF: Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM
(1997). Single-patient data meta-analysis of 3,453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain
(2004). SZ: Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
(2000). Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain
(2002). The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology
(2004). TM: Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.